Distinct mechanisms responsible for the increase in glucose production and ketone formation caused by empagliflozin in T2DM patients
Abdelgani S, Khatab A, Adams J, et al.
Diabetes Care. 2023;dc220885.
Leggi
Abdelgani S, Khatab A, Adams J, et al.
Diabetes Care. 2023;dc220885.
Leggi
Thorsen SU, Liu X, Kataria Y, et al.
Diabetes Care. 2023;dc221359.
Leggi
Pigeyre M, Gerstein H, Ahlqvist E, et al.
Diabetologia. Pub. online 1 Mar 2023.
Leggi
Aburisheh K, AlKheraiji MF, Alwalan SI, et al.
BMC Endocr Disord. 2023;23(1):50.
Leggi
Khan J, Pernicova I, Nisar K, Korbonits M
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00001-3.
Leggi
Yeggalam A, Liebich JA, Yu K, et al.
Diabetes Obes Metab. Pub online 27 Feb 2023.
Leggi
Stentebjerg LL, Madsen LR, Støving RK, et al.
Diabetes Care 2023;46(3):502-510
Leggi
Corbin KD, Dagogo-Jack S, Cannon CP, et al.
Diabetes Obes Metab. 2023;25(3):758-766.
Leggi
Rossing P, Garweg JG, Anker SD, et al.
Diabetes Obes Metab. 2023;25(3):894-89.
Leggi
Liu J, Pan H, Liu Y, et al.
NMCD. Pub online 27 Feb 2023.
Leggi